C heng Zhenghui is a Chinese billionaire whose fortune is derived from his family's stake in Shanghai RAAS Blood Products, a leading Chinese company in the blood plasma industry. Blood products, such as albumin and immunoglobulin, are essential for treating a variety of medical conditions, including immune disorders and shock. The company is a key player in this critical part of the healthcare sector.
The company was founded by a Vietnamese-American, but the Cheng family, along with other investors, are now the main shareholders. The company has grown by expanding its network of plasma collection centers and its manufacturing capacity. The demand for blood products in China is immense and growing, and as a leader in this highly regulated industry, Shanghai RAAS has achieved a significant valuation on the Shenzhen Stock Exchange, which is the source of the family's wealth.
Advertisement
Cheng Zhenghui is a Chinese businessman and the founder and Chairman of APT Medical (APT), a leading manufacturer and supplier of interventional medical devices. His wealth is rooted in the high-growth, specialized sector of cardiovascular and cerebrovascular medicine. APT is headquartered in the southern Chinese business hub of Shenzhen.
His career is defined by his commitment to medical technology and the development of sophisticated, minimally invasive tools. Cheng Zhenghui founded the company in 2002, recognizing the immense need for domestic production of high-quality, specialized catheters and medical devices, a market often dominated by international firms. His vision was to advance interventional medicine utilizing local technologies and innovations.
Cheng Zhenghui founded APT Medical (formerly Shenzhen Huitai Medical Devices) in 2002. His strategic vision was to build a company committed to advancing interventional medicine through the development of essential medical devices, particularly focusing on electrophysiology (EP) and vascular intervention (cardiovascular and cerebrovascular). This specialization allowed APT to quickly gain market credibility.
The company successfully scaled its product portfolio—including 3D mapping systems, mapping catheters, and ablation catheters—by collaborating closely with clinicians, hospitals, and academic institutions. The culmination of this growth was APT Medical's successful IPO on the Shanghai Stock Exchange (SSE) in 2021, securing Cheng's multi-billion dollar fortune. APT is now a major supplier, exporting its specialized tools to over 90 countries and achieving a high compound annual growth rate.
Advertisement
Founds APT Medical (Shenzhen Huitai Medical Devices) (Founding).
Drives the company's focus on electrophysiology and vascular intervention devices (Strategic Focus).
APT Medical executes its successful IPO on the Shanghai Stock Exchange (Financial Milestone).
Continues as Chairman, guiding the company's global expansion (Executive Leadership).
Cheng Zhenghui's wealth is concentrated in his founding equity and continued executive leadership of the publicly listed medical device giant, APT Medical (SSE: 688617).
Advertisement
Cheng Zhenghui's social impact is massive and humanitarian, stemming from APT Medical's role in advancing interventional medicine. His company provides essential, high-quality medical devices (catheters, surgical tools) that allow healthcare professionals to confidently tackle complex cardiovascular and cerebrovascular challenges, directly improving patient outcomes globally.
The company's commitment to innovation rooted in clinical needs is a structural contribution to medical advancement. His personal philanthropy supports medical research and community health initiatives.
Cheng Zhenghui maintains the professional, composed style of a Chinese medical technology executive. His attire is consistently formal and high-quality, favoring tailored business suits. His aesthetic is one of serious authority and stability, befitting a multi-billion dollar executive commanding a crucial part of the global medical supply chain.
Residing in Shenzhen, his luxury is the immense security and financial reward derived from his dominance in a crucial, high-tech industrial sector. His life is defined by his commitment to technical precision and advancing human health through specialized medical devices.
Advertisement
No publicly available quotes.
Advertisement
+15.28% | +$199.47M
+1.42% | +$112.00M
This profile is compiled from verified biographical and financial records:
All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.
If you find any inaccuracies, please report them to admin@redcarpetlife.in
Sponsored Content